American National Bank & Trust’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

American National Bank & Trust’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-47	Closed	-$6.2K	–	733
2025 Q1	$6.2K	Buy	+47	New	+$5.86K	﹤0.01%	495

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

American National Bank & Trust's ITCI Position: Q2 2025 in Review

American National Bank & Trust sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 47 shares — an estimated $6.2K sold.

American National Bank & Trust first reported a position in ITCI in Q1 2025 and held it in 1 quarter. The position peaked at $6.2K in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

American National Bank & Trust reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
American National Bank & Trust sold 47 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $6.2K.
American National Bank & Trust first reported a position in Intra-Cellular Therapies Inc. in Q1 2025 and held it in 1 quarter.
American National Bank & Trust's Intra-Cellular Therapies Inc. position peaked at $6.2K in Q1 2025.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on American National Bank & Trust's 13F filing for Q2 2025, filed 16 Jul 2025.